# Real-World Effectiveness of Mavacamten in Canada

> **NCT06338202** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 115 (actual)

## Conditions studied

- Obstructive Hypertrophic Cardiomyopathy (oHCM)

## Interventions

- **DRUG:** Mavacamten

## Key facts

- **NCT ID:** NCT06338202
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-24
- **Primary completion:** 2024-11-12
- **Final completion:** 2024-12-19
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06338202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06338202, "Real-World Effectiveness of Mavacamten in Canada". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06338202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*